IS6369A - Aðferð til þess að spá fyrir um batahorfur og tilsjúkdómsgreiningar á krabbameini - Google Patents
Aðferð til þess að spá fyrir um batahorfur og tilsjúkdómsgreiningar á krabbameiniInfo
- Publication number
- IS6369A IS6369A IS6369A IS6369A IS6369A IS 6369 A IS6369 A IS 6369A IS 6369 A IS6369 A IS 6369A IS 6369 A IS6369 A IS 6369A IS 6369 A IS6369 A IS 6369A
- Authority
- IS
- Iceland
- Prior art keywords
- cancer
- predicting
- prognosis
- diagnosis
- cancer diagnosis
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4718—Lipocortins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/44—Multiple drug resistance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- General Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16334099P | 1999-11-03 | 1999-11-03 | |
| PCT/US2000/030467 WO2001033228A2 (en) | 1999-11-03 | 2000-11-03 | Cancer diagnosis employing cell-sorting and gene-profiles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS6369A true IS6369A (is) | 2002-04-30 |
Family
ID=22589604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS6369A IS6369A (is) | 1999-11-03 | 2002-04-30 | Aðferð til þess að spá fyrir um batahorfur og tilsjúkdómsgreiningar á krabbameini |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US6511806B1 (is) |
| EP (1) | EP1283904A2 (is) |
| AU (1) | AU1465801A (is) |
| CA (1) | CA2390305A1 (is) |
| IS (1) | IS6369A (is) |
| WO (1) | WO2001033228A2 (is) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040023375A1 (en) * | 2002-07-30 | 2004-02-05 | Precision Therapeutics, Inc. | Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays |
| US5728541A (en) * | 1996-07-12 | 1998-03-17 | Precision Therapeutics, Inc. | Method for preparing cell cultures from biologial specimens for chemotherapeutic and other assays |
| US20040072722A1 (en) | 2002-10-10 | 2004-04-15 | Kornblith Paul L. | Methods for assessing efficacy of chemotherapeutic agents |
| EP1283904A2 (en) * | 1999-11-03 | 2003-02-19 | Oncotech, Inc. | Cancer diagnosis using cell-sorting and gene-expression-profiles |
| US7635676B2 (en) | 2001-02-21 | 2009-12-22 | Alavita Pharmaccuticals, Inc. | Modified annexin proteins and methods for their use in organ transplantation |
| US7635680B2 (en) | 2001-02-21 | 2009-12-22 | Alavita Pharmaceuticals, Inc. | Attenuation of reperfusion injury |
| US7645739B2 (en) | 2001-02-21 | 2010-01-12 | Alavita Pharmaceuticals, Inc. | Modified annexin compositions and methods of using same |
| CA2455649C (en) * | 2001-07-23 | 2009-11-10 | Yoshihiko Hamamoto | Scoring system for the prediction of cancer recurrence |
| US20040086888A1 (en) * | 2001-10-18 | 2004-05-06 | Kornblith Paul L | Method for tandem genomic/proteomic analysis of proliferating cells |
| US20040214314A1 (en) * | 2001-11-02 | 2004-10-28 | Friedrich Srienc | High throughput bioreactor |
| AU2003235749A1 (en) * | 2002-01-07 | 2003-07-24 | John Hopkins University | Biomarkers for detecting ovarian cancer |
| US20050214760A1 (en) * | 2002-01-07 | 2005-09-29 | Johns Hopkins University | Biomarkers for detecting ovarian cancer |
| US8008012B2 (en) * | 2002-01-24 | 2011-08-30 | Health Discovery Corporation | Biomarkers downregulated in prostate cancer |
| EP1361433A3 (en) * | 2002-04-09 | 2005-02-23 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Method for estimating therapeutic efficacy of tumor necrosis factor (TNF) |
| KR101107765B1 (ko) * | 2002-08-06 | 2012-01-25 | 싸이퍼젠 바이오시스템즈, 인코포레이티드 | 난소암의 검출을 위한 생물 마커의 용도 |
| WO2007057746A2 (en) * | 2005-05-27 | 2007-05-24 | Aurelium Biopharma Inc. | Focused microarray and methods of diagnosing chemotherapeutic drug resistance in a cancer cell |
| WO2007028146A2 (en) * | 2005-09-01 | 2007-03-08 | Precision Therapeutics, Inc. | Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics |
| CA2623445A1 (en) * | 2005-09-21 | 2007-03-29 | Ccc Diagnostics, Llc | Comprehensive diagnostic testing procedures for personalized anticancer chemotherapy (pac) |
| EP2027465A2 (en) | 2006-05-17 | 2009-02-25 | Cellumen, Inc. | Method for automated tissue analysis |
| WO2007139895A2 (en) * | 2006-05-24 | 2007-12-06 | Cellumen, Inc. | Method for modeling a disease |
| US10018631B2 (en) | 2011-03-17 | 2018-07-10 | Cernostics, Inc. | Systems and compositions for diagnosing Barrett's esophagus and methods of using the same |
| WO2017091658A1 (en) | 2015-11-25 | 2017-06-01 | Cernostics, Inc. | Methods of predicting progression of barrett's esophagus |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4996145A (en) * | 1987-10-27 | 1991-02-26 | Oncotech Incorporated | Method for detecting immune-mediated cytotoxicity |
| US6040138A (en) * | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| US5153117A (en) * | 1990-03-27 | 1992-10-06 | Genetype A.G. | Fetal cell recovery method |
| EP0834575B1 (en) * | 1990-12-06 | 2001-11-28 | Affymetrix, Inc. (a Delaware Corporation) | Identification of nucleic acids in samples |
| US5464753A (en) | 1991-03-08 | 1995-11-07 | Univ Illinois | Purification and manipulation of bone marrow and blood cells on the basis of P-glycoprotein expression |
| US5994088A (en) * | 1991-03-08 | 1999-11-30 | Board Of Trustees Of The University Of Illinois | Methods and reagents for preparing and using immunological agents specific for P-glycoprotein |
| WO1995021381A1 (en) * | 1994-02-01 | 1995-08-10 | The Rockefeller University | Methods and agents for measuring and controlling multidrug resistance |
| CA2185535C (en) | 1994-04-11 | 2000-10-24 | Christiaan Peter Maria Reutelingsperger | A method for detecting and/or optionally quantifying and/or separating apoptotic cells in or from a sample |
| US5795790A (en) * | 1994-07-20 | 1998-08-18 | Cytotherapeutics, Inc. | Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organs |
| US5736129A (en) * | 1995-11-17 | 1998-04-07 | Medenica; Rajko D. | Flow cytometric pharmacosensitivity assay and method of cancer treatment |
| US5994077A (en) * | 1997-01-31 | 1999-11-30 | The Board Of Trustees Of The Leland Stanford Junior University | Flourescence-based isolation of differentially induced genes |
| US6165709A (en) | 1997-02-28 | 2000-12-26 | Fred Hutchinson Cancer Research Center | Methods for drug target screening |
| DE69822206T2 (de) | 1997-12-19 | 2005-02-17 | Affymetrix, Inc., Santa Clara | Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen |
| WO1999050401A1 (fr) | 1998-03-27 | 1999-10-07 | Helix Research Institute | Procede pour detecter les changements de l'expression genique par le traitement avec un compose de test |
| US6004755A (en) | 1998-04-07 | 1999-12-21 | Incyte Pharmaceuticals, Inc. | Quantitative microarray hybridizaton assays |
| WO1999057306A2 (en) | 1998-05-01 | 1999-11-11 | Queen's University At Kingston | Method for diagnosing a vascular condition |
| US6406693B1 (en) * | 1998-07-13 | 2002-06-18 | Board Of Regents, The University Of Texas System | Cancer treatment methods using antibodies to aminophospholipids |
| US6617426B1 (en) * | 1999-06-22 | 2003-09-09 | Merck & Co Inc | Cysteinyl protease inhibitors |
| EP1283904A2 (en) * | 1999-11-03 | 2003-02-19 | Oncotech, Inc. | Cancer diagnosis using cell-sorting and gene-expression-profiles |
-
2000
- 2000-11-03 EP EP00976955A patent/EP1283904A2/en not_active Withdrawn
- 2000-11-03 US US09/705,320 patent/US6511806B1/en not_active Expired - Fee Related
- 2000-11-03 WO PCT/US2000/030467 patent/WO2001033228A2/en not_active Ceased
- 2000-11-03 CA CA002390305A patent/CA2390305A1/en not_active Abandoned
- 2000-11-03 AU AU14658/01A patent/AU1465801A/en not_active Abandoned
-
2002
- 2002-04-30 IS IS6369A patent/IS6369A/is unknown
- 2002-11-15 US US10/295,188 patent/US7323300B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7323300B2 (en) | 2008-01-29 |
| US20030096290A1 (en) | 2003-05-22 |
| CA2390305A1 (en) | 2001-05-10 |
| WO2001033228A9 (en) | 2003-01-30 |
| WO2001033228A3 (en) | 2002-11-14 |
| EP1283904A2 (en) | 2003-02-19 |
| US6511806B1 (en) | 2003-01-28 |
| WO2001033228A2 (en) | 2001-05-10 |
| AU1465801A (en) | 2001-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS6369A (is) | Aðferð til þess að spá fyrir um batahorfur og tilsjúkdómsgreiningar á krabbameini | |
| NO20022955L (no) | Fremgangsmåte og anordning til overföring og til mottak av informasjon | |
| NO20015179D0 (no) | Anordning og fremgangsmåte for venturispyling | |
| EP0975803A4 (en) | METHOD FOR EVALUATING PROSTATE CANCER | |
| EG23358A (en) | Method and apparatus for borehole sensing. | |
| NO990784L (no) | Anordninger og fremgangsmåter til fullförelse av en brönnboring | |
| NO20012931D0 (no) | Nye tyroidreseptorligander og fremgangsmåte II | |
| NO980605D0 (no) | Fremgangsmåter og anordning for komplettering av underjordisk brönn | |
| IS5411A (is) | Aðferðir og milliefni til framleiðslu á efnasambandi gegn krabbameini | |
| NO992351D0 (no) | Pµl og fremgangsmÕte for installasjon av denne | |
| FI980373A7 (fi) | Menetelmä matkaviestimen tietojen käsittelemiseksi | |
| ID30263A (id) | Metode untuk penyegelan melingkar | |
| NO20015067D0 (no) | Fremgangsmåte og anordning for testing av en brönn | |
| NO20025416L (no) | System og fremgangsmåte ved ekspanderbar komplettering | |
| NO980603D0 (no) | Fremgangsmåte og anordning for komplettering av en underjordisk brönn | |
| NO980602D0 (no) | Fremgangsmåte og anordning for komplettering av en underjordisk brönn | |
| NO20020577L (no) | Trediminsjonal flerfase-tunneleringsmetode og anordning derfor | |
| DK0992794T3 (da) | Enzym-antistofkompleks og en fremgangsmåde til fremstilling heraf | |
| NO20021247D0 (no) | Fremgangsmåte og system for oppgradering av programvare | |
| NO20002584D0 (no) | Brønnreferanseapparat og fremgangsmÕte | |
| FI982651L (fi) | Menetelmä tiedonsiirron optimoimiseksi | |
| NO20000188D0 (no) | Fremgangsmåte og anordning for sidebroenntilknytning | |
| DK0978681T3 (da) | Foringspose til grenrör og fremgangsmåde til rörforing | |
| DE69808346D1 (de) | Rohrauskleidungsverfahren | |
| NO993718L (no) | Innretning og fremgangsmåte for selektiv posisjonering av en anordning og manipulering av denne |